EMEA-000176-PIP01-07-M05
Key facts
| Invented name |
Colobreathe
|
| Active substance |
Colistimethate sodium
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0173/2017
|
| PIP number |
EMEA-000176-PIP01-07-M05
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of Pseudomonas aeruginosa pulmonary infection / colonisation in patients with cystic fibrosis
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
TEVA B.V.
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|